Lehman Financial Resources, Inc. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lehman Financial Resources, Inc. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2015$1,0000.0%2000.0%0.00%
Q2 2015$1,0000.0%2000.0%0.00%
Q1 2015$1,0000.0%2000.0%0.00%
Q4 2014$1,0000.0%2000.0%0.00%
-100.0%
Q3 2014$1,0002000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2015
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,227,832$856,0000.04%
FT Options LLC 15,000$10,0000.01%
BLUESTEIN R H & CO LLC 112,200$78,0000.01%
SABBY MANAGEMENT, LLC 203,097$142,0000.01%
TWO SIGMA SECURITIES, LLC 16,701$12,0000.00%
Klingman & Associates, LLC 10,000$7,0000.00%
TFS CAPITAL LLC 13,627$10,0000.00%
OPPENHEIMER & CO INC 75,500$53,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$72,0000.00%
Virtu KCG Holdings LLC 48,827$34,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders